Response to Flutamide Withdrawal in Advanced Prostate Cancer in Progression Under Combination Therapy-Reference-Cited by-同舟云学术

Response to Flutamide Withdrawal in Advanced Prostate Cancer in Progression Under Combination Therapy

Published:1993-09 Issue:3 Volume:150 Page:908-913
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Dupont André¹,Gomez José-Luis¹,Cusan Leonello¹,Koutsilieris Michael¹,Labrie Fernand¹

Affiliation:

1. From the Clinical Research Unit, CHUL Research Center and Laval University, Quebec, Canada

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference60 articles.

1. Studies on prostatic cancer. Effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate;Huggins;Cancer Res.,1941

2. Treatment and survival of patients with cancer of the prostate;Surg., Gynec. & Obst.,1967

3. Recent patterns of care of prostate cancer patients in the United States: results from the surveys of the American College of Surgeons Commission on Cancer;Mettlin;Int. Adv. Surg. Oncol.,1982

4. Antifertility effects of LHRH agonists in the male;Labrie;J. Androl.,1980

5. New hormonal therapy in prostatic carcinoma: combined treatment with an LHRH agonist and an antiandrogen;Labrie;Clin. Invest. Med.,1982

Cited by 130 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prostate Cancer, Version 4.2023, NCCN Clinical Practice Guidelines in Oncology;Journal of the National Comprehensive Cancer Network;2023-10

2. PSA response to antiandrogen withdrawal: a systematic review and meta-analysis;Prostate Cancer and Prostatic Diseases;2021-02-18

3. Androgen Receptor Targeted Treatments of Prostate Cancer: 35 Years of Progress with Antiandrogens;Journal of Urology;2018-11

4. FOUR MOST LIFE THREATENING UROGENITAL CANCER AND ITS MANAGEMENT;International Journal of Pharmaceutical Sciences and Research;2018-08-01

5. Antiandrogen withdrawal syndrome (AAWS) in the treatment of patients with prostate cancer;Endocrine-Related Cancer;2018-01